Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel with Chemoradiation for Esophageal Cancer
NCT00002984Phase 2Completed
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- Mar 1997
- Primary completion
- May 2006
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection in esophageal cancer, sponsored by UNC Lineberger Comprehensive Cancer Center. Started Mar 1997; status: completed.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT00002984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002984.